TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/24 20:54 | 3/19/24 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Meeker David P | MA | DO | P,CEO | S | -1,784 | 39.22 | 0 | -45 | -21 | 175 | D | ||||||||||||||
2/5/24 18:53 | 2/1/24 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Meeker David P | MA | DO | P,CEO | S.d | -197 | 45.06 | 0 | -4 | -3 | 121 | D | ||||||||||||||
5/26/10 18:26 | 5/25/10 | GENZ | Genzyme Corp | MA | Health | BioPrd | Biological Products, (No Diag | Meeker David P | MA | O | ExecVP,C | S.d | -125 | 45.60 | 0 | -3 | -19 | 11 | D | ||||||||||||||
5/25/10 14:20 | 5/21/10 | GENZ | Genzyme Corp | MA | Health | BioPrd | Biological Products, (No Diag | Meeker David P | MA | O | ExecVP,C | S.d | -809 | 49.06 | 0 | -16 | -73 | 6 | D | ||||||||||||||
8/18/08 13:58 | 8/15/08 | GENZ | Genzyme Corp | MA | Health | BioPrd | Biological Products, (No Diag | Meeker David P | CT | O | P LSD Th | S.d | -1,480 | 83.19 | 0 | -18 | -85 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |